Mumbai, Maharashtra, India, Monday, September 30, 2013 -- (Business Wire India)
Abbott has been named the ‘Multinational Pharmaceutical Company of the Year'
for the third consecutive year at the 2013 Frost & Sullivan India Healthcare
Excellence Awards held in Mumbai on Friday.
The prestigious annual award from Frost and Sullivan acknowledges best practices
in the healthcare industry and measures companies on parameters such as revenue
and market share growth, geographical and product line expansion, visibility of
the company, value-added services, strategic and technological innovation, and
clinical excellence. Abbott was recognised for its outstanding performance
against these criteria in 2012-2013.
With a heritage of over 100 years in India, Abbott is committed to investing in
building its local capabilities — through people, infrastructure, innovation
and partnerships — while benefiting from being a part of one of the world's
leading healthcare companies.
Congratulating Abbott on the award, Sandeep Sinha, Director, Healthcare and Life
Sciences Practice, Frost & Sullivan, said, "Our analysis shows that Abbott
India's success is a combination of a diversified product portfolio, focused
execution, and attention to fulfilling the unmet health needs of patients.
Abbott's performance and growth represents continuous efforts in terms of
innovation, accessibility, and affordability of medicine to patients at large in
Commenting on the award, Rehan A. Khan, Managing Director, Abbott India Ltd,
said, “As one of India's oldest healthcare companies, we take pride in
applying our knowledge and expertise to help address the country's most relevant
healthcare challenges and needs. Abbott is honoured to be recognised for our
commitment to improving access to high-quality and affordable, branded generic
medicines that have been successfully treating patients for many years.”
Abbott is one of the leading healthcare companies in India, providing consumers
with a diverse range of established pharmaceuticals, nutritional products,
medical devices, and diagnostic tests. Also ranked the number one company in the
Indian pharmaceutical market1, Abbott has 20 pharmaceutical brands in the Top
300 in the country and has substantial expertise and a strong presence in
important therapy areas like cardio-metabolic, gastroenterology, women's health,
neurosciences, cough management, antibiotics, pain and dermatology.
About the Frost & Sullivan Annual India Healthcare Excellence Awards 2013
The coveted Frost & Sullivan India Healthcare Excellence Awards are presented to
companies that demonstrate best practices in the Indian Healthcare and Life
sciences industry. These awards are a boost for organizations not only because
of the recognition they bring, but also in terms of industry standings. The
award categories span across various healthcare segments such as Pharmaceuticals
and Biotechnology, Medical Technologies, Healthcare Delivery Services and
Special Awards. The awards program follows a rigorous methodology to recognize
superior planning and execution of product launches, strategic alliances,
distribution strategies, technological innovations, customer services,
healthcare delivery services, and mergers and acquisitions. A host of other
crucial factors such as leadership, strategy, growth, service, innovation,
integration, marketing, financial performance, and development are also
considered as part of the award methodology. These awards are in keeping with
Frost & Sullivan's commitment to recognize innovative growth strategies and
solutions adopted by the best companies in the healthcare industry.
Abbott is a global healthcare company devoted to improving life through the
development of products and technologies that span the breadth of healthcare.
With a portfolio of leading, science-based offerings in diagnostics, medical
devices, nutritionals and branded generic pharmaceuticals, Abbott serves people
in more than 150 countries and employs approximately 70,000 people.
In India, Abbott has more than 12,000 employees working in manufacturing,
research and development, logistics, sales and marketing and is headquartered in
Visit Abbott at www.abbott.com and connect with us on Twitter at @AbbottNews.
1 ORG IMS, Secondary Sales Audit July 2013
To view the photograph, please click on the link given below:
Mr. Rehan Khan, MD, Abbott India, receiving the F&S award at the hands of DG
Shah, Secretary-General, Indian Pharmaceutical Alliance
Media contact details
Varsha Chainani, Dir, Public Affairs,
Contributed via: Bloomberg Publisher WEB Service
Provider ID: 28e3151d98a34c97b5cf4b0fbb64e77a
-0- Oct/01/2013 10:08 GMT
Press spacebar to pause and continue. Press esc to stop.